Navigation Links
Anemia Drugs May Speed Tumor Growth in Some Cancer Patients
Date:6/1/2008

Widely prescribed blood-boosters might stimulate malignant cells, hasten death, study says

SUNDAY, June 1 (HealthDay News) -- Drugs used widely to treat anemia in cancer patients may actually speed progression of the cancer in certain individuals, but researchers report they may found a way to determine who those individuals are.

"We may have a test to predict whether a patient is susceptible to having their tumor progress if treated with erythropoietin and, alternatively, we may be able to predict patients it would be safe to treat with erythropoietin," study author Dr. Tony Blau, of the University of Washington in Seattle, said during a Sunday news conference at the American Society of Clinical Oncology annual meeting in Chicago.

Recent controversy over erythropoiesis-stimulating agents (ESAs) such as Procrit, Epogen and Aranesp has centered around whether the blood-boosting drugs should be withdrawn from the market because of troubling side effects.

In March, a U.S. Food and Drug Administration advisory panel voted to recommend continued use of the drugs for patients on chemotherapy, unless the patient is likely to be cured. They also voted to recommend against the drugs' use in patients with breast or head and neck cancer.

Eight clinical trials now suggest these medications actually speed the growth of tumors and shorten the lives of cancer victims.

The drugs' manufacturers added a "black box" warning to the medications last November.

"There has been lots of controversy over these stimulating agents, and we have an FDA advisory committee to act on this as we speak," said Dr. Julie Gralow, director of breast oncology at the University of Washington and Fred Hutchinson Cancer Center in Seattle and moderator of the Sunday news conference. "The drugs offer benefits in terms of reducing anemia and reducing transfusions, but several large trials in a variety of tumor types suggest that
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mission Pharmacal Launches Ferralet(R) 90 for Treatment of the Leading Cause of Anemia in the U.S.
2. Twin findings raise hopes of improved anemia treatments
3. Anemia Triples Risk of Local Recurrence in Breast Cancer Patients
4. FDA Panel Supports Anemia Drugs for Cancer Patients
5. FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients
6. UT Southwestern researchers investigate predictors for sickle-cell-anemia complications
7. Drugs used for cancer-associated anemia linked with increased risk of blood clots, death
8. Anemia Drugs for Cancer Patients Increase Death Risk
9. Anemia treatment may be a double-edged sword
10. FDA Reports New Risks Posed by Anemia Drugs
11. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... in the Dec. 15 issue of the Journal ... or obese increases the risk for developing obstructive sleep ... , Results indicate that the risk of ... older increased 3.5 fold with each standard-deviation increase in ... OSA did not significantly increase with increasing BMI among ...
(Date:12/14/2009)... BROOK, Ill., Dec. 15 In today,s ... larger role than ever. Now the University HealthSystem ... resources, Value Analysis: Achieving Cost Efficiencies in ... in these complex environments. These new materials, developed ... the field, provide a practical guide to planning, ...
(Date:12/14/2009)... PARK, Ill. and HOLLYWOOD, Fla., Dec. 14 ... ) announced today a definitive agreement to ... ), a leading provider of laboratory information ... cash. ,, The acquisition strengthens Abbott,s ... providing advanced web-based applications to help laboratories ...
(Date:12/14/2009)... Dec. 14 Aflac Incorporated announced today ... of thirty-year senior notes with a coupon of ... price of 98.951 to yield 6.984%. The company ... debt repayment and general corporate purposes. ,, Commenting ... Incorporated President and Chief Financial Officer Kriss Cloninger ...
(Date:12/14/2009)... in one gene, researchers say , , MONDAY, Dec. 14 ... genetic variants in a single gene linked to heart ... Medicine in St. Louis analyzed the DNA of a ... identified 129 variants in four genes that could be ... with heart failure and 625 healthy whites led the ...
Breaking Medicine News(10 mins):Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4
... The Executives, a support group of nearly 500 prominent ... funds for the Los Angeles Jewish Home, presented its ... the group,s president, and the Jack Schlaifer Visionary Award ... awards lunch and installation event.The Tom Bane Humanitarian Award ...
... the "standard of care" for patients with complex coronary ... New England Journal of Medicine (online February ... study, led jointly by Patrick Serruys from Erasmus University ... the University of Leipzig (Germany), set out to compare ...
... Indicates Improper Revenue Accounting Related to Two Transactions , ... a world leader in stabilized rice bran (SRB) nutrient ... preliminary findings and recommendations of the Audit Committee of ... statements for the fiscal year ended December 31, 2007. ...
... Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the ... it will be exhibiting at the upcoming Chicago Dental ... of its highly successful sales of the STA ... year,s CDS conference, coupled with four successive quarters of ...
... DataMentors(R), the industry leading full-service data quality ... release of its much anticipated DataFuse(TM) version 5.0. ... platforms. DataFuse is used by a diverse cross-section ... companies, providing the industry,s highest level of data ...
... a new chapter of your life can be a scary ... graduating from college, getting married, having your first child, or ... overwhelmed with how this change affects the rest of your ... a Difference" ( published by AuthorHouse ) by Robert C.K. ...
Other Medicine News:Health News:Los Angeles Jewish Home Support Group Presents Humanitarian Award and Visionary Award 2Health News:Los Angeles Jewish Home Support Group Presents Humanitarian Award and Visionary Award 3Health News:SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents 2Health News:SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents 3Health News:SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents 4Health News:NutraCea to Restate Financial Statements for 2007 and 2008 2Health News:NutraCea to Restate Financial Statements for 2007 and 2008 3Health News:NutraCea to Restate Financial Statements for 2007 and 2008 4Health News:NutraCea to Restate Financial Statements for 2007 and 2008 5Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 2Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 3Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 4Health News:Industry Leading Data Quality and Householding Software Receives New Functionality for Enhanced Performance and Speed 2Health News:'Standing on the Edge of Tomorrow: You Can Make a Difference' 2
(Date:12/14/2009)... -- Cardinal Health today announced that executives of the ... Goldman Sachs CEO Unplugged Conference on ... Conference Center in New York. 28th Annual ... Noon EST at the Westin St. Francis Hotel in ... will discuss Cardinal Health,s diverse products and services, company ...
(Date:12/14/2009)... CARROLLTON, Ga., Dec. 14 /PRNewswire/ ... that its flagship integrated EHR, Prime Suite ... conditionally CCHIT Certified(®) 2011 Ambulatory EHR, additionally ... with optional Advanced Reporting. Greenway,s Prime Suite ... two new 2011 certification designations offered by ...
(Date:12/14/2009)... Therapeutics (NYSE Amex: CXM ) announced a ... in the Treatment of Diabetic Ulcers," at the ... held December 10-13, 2009 in St. Thomas, U.S. ... top industry leaders and renowned researchers in the ... K. Sosnowski, Cardium,s Vice President of Biologics Development ...
Breaking Medicine Technology:Cardinal Health Executives to Speak at Two Investor Events in January 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4554 000 in Massachusetts Struggle to Put Food on the Table 61847 1554 000 in Massachusetts Struggle to Put Food on the Table 61847 2554 000 in Massachusetts Struggle to Put Food on the Table 61847 3554 000 in Massachusetts Struggle to Put Food on the Table 61847 4Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 1Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 2Heritage Provider Network CEO Dr Richard Merkin Announces the Acquisition of Lakeside Medical Systems Inc 61839 1Heritage Provider Network CEO Dr Richard Merkin Announces the Acquisition of Lakeside Medical Systems Inc 61839 2Heritage Provider Network CEO Dr Richard Merkin Announces the Acquisition of Lakeside Medical Systems Inc 61839 3
... efficacy and safety of once-daily TMC278 in ... treatment-naive adults with ... phase IIb data from Tibotec,Pharmaceuticals Ltd. provides additional information ... investigational,non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV,combination ...
... Interferon-Beta-CTP Development Program Has Been Approved For, First Year Funding Through ... ... Chief Scientist -, NES-ZIONA, Israel, Aug. 5 ... subsidiary,has received approval for a special grant from the Israeli Office ...
Other Medicine Technology:Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 2Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 3Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: